Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1968 1
1969 1
1974 2
1975 1
1980 1
1981 1
1987 1
1990 4
1991 2
1992 3
1993 1
1994 4
1995 3
1996 5
1997 9
1998 15
1999 16
2000 16
2001 16
2002 23
2003 11
2004 16
2005 18
2006 15
2007 14
2008 20
2009 21
2010 15
2011 40
2012 49
2013 35
2014 38
2015 34
2016 25
2017 36
2018 46
2019 37
2020 46
2021 26
2022 32
2023 21
2024 27

Search Results

679 results

Results by year

Filters applied: . Clear all
Page 1
An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth.
Morgenstern A, Apostolidis C, Kratochwil C, Sathekge M, Krolicki L, Bruchertseifer F. Morgenstern A, et al. Curr Radiopharm. 2018;11(3):200-208. doi: 10.2174/1874471011666180502104524. Curr Radiopharm. 2018. PMID: 29732998 Free PMC article. Review.
Targeted α-Therapy.
Brechbiel MW. Brechbiel MW. Cancer Biother Radiopharm. 2020 Aug;35(6):397. doi: 10.1089/cbr.2020.29008.mbr. Epub 2020 Jun 5. Cancer Biother Radiopharm. 2020. PMID: 32503377 No abstract available.
Targeted and Nontargeted α-Particle Therapies.
McDevitt MR, Sgouros G, Sofou S. McDevitt MR, et al. Annu Rev Biomed Eng. 2018 Jun 4;20:73-93. doi: 10.1146/annurev-bioeng-062117-120931. Epub 2018 Jan 18. Annu Rev Biomed Eng. 2018. PMID: 29345977 Free PMC article. Review.
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy.
Bidkar AP, Wang S, Bobba KN, Chan E, Bidlingmaier S, Egusa EA, Peter R, Ali U, Meher N, Wadhwa A, Dhrona S, Dasari C, Beckford-Vera D, Su Y, Tang R, Zhang L, He J, Wilson DM, Aggarwal R, VanBrocklin HF, Seo Y, Chou J, Liu B, Flavell RR. Bidkar AP, et al. Clin Cancer Res. 2023 May 15;29(10):1916-1928. doi: 10.1158/1078-0432.CCR-22-3291. Clin Cancer Res. 2023. PMID: 36917693 Free PMC article.
Patient-specific alpha-particle dosimetry.
Palm S, Elgqvist J, Jacobsson L. Palm S, et al. Curr Radiopharm. 2011 Oct;4(4):329-35. doi: 10.2174/1874471011104040329. Curr Radiopharm. 2011. PMID: 22202155 Review.
Why bother with alpha particles?
King AP, Lin FI, Escorcia FE. King AP, et al. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):7-17. doi: 10.1007/s00259-021-05431-y. Epub 2021 Jun 27. Eur J Nucl Med Mol Imaging. 2021. PMID: 34175980
Targeted Alpha Therapy: Current Clinical Applications.
Guerra Liberal FDC, O'Sullivan JM, McMahon SJ, Prise KM. Guerra Liberal FDC, et al. Cancer Biother Radiopharm. 2020 Aug;35(6):404-417. doi: 10.1089/cbr.2020.3576. Epub 2020 Jun 16. Cancer Biother Radiopharm. 2020. PMID: 32552031 Review.
Alpha-particles for targeted therapy.
Sgouros G. Sgouros G. Adv Drug Deliv Rev. 2008 Sep;60(12):1402-6. doi: 10.1016/j.addr.2008.04.007. Epub 2008 Apr 23. Adv Drug Deliv Rev. 2008. PMID: 18541332 Review.
679 results